Enhanced airway inflammation and decreased subepithelial fibrosis in interleukin 6‐deficient mice following chronic exposure to aerosolized antigen
- 9 July 2004
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 34 (8) , 1321-1328
- https://doi.org/10.1111/j.1365-2222.2004.02013.x
Abstract
Airway inflammation and remodelling are characteristic features of chronic asthma. To elucidate the role of interleukin (IL)-6 in airway responses to chronic antigen exposure. We compared airway inflammation, subepithelial collagen deposition, cytokine mRNA expression, and airway responsiveness between IL-6-deficient and wild-type (WT) mice following sensitization and repeated exposure to ovalbumin (OVA) three times a week for 8 weeks. The repeated exposure to OVA induced infiltration of eosinophils, neutrophils, and lymphocytes into the airway, and caused thickening of the basement membrane and subepithelial fibrosis. IL-6-deficient mice exhibited more pronounced infiltration of these cells, a thinner basement membrane, and decreased subepithelial fibrosis, compared with WT mice. The repeated OVA exposure increased expression of IL-4, IL-13, eotaxin, monocyte chemoattractant protein-1 (MCP-1), and transforming growth factor-beta1 mRNA in WT mice. Among these factors, expression of IL-13 and MCP-1 mRNA was further enhanced in IL-6-deficient mice, compared with WT mice. However, both WT and IL-6-deficient mice exhibited similar levels of airway responsiveness to increasing doses of methacholine, even after repeated exposure to OVA. These results suggest that IL-6 has dual roles in the chronic phase of asthma: down-regulation of inflammatory cell infiltration and enhancement of airway remodelling.Keywords
This publication has 42 references indexed in Scilit:
- Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1Journal of Clinical Investigation, 1999
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998
- Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T CellsThe Journal of Experimental Medicine, 1997
- Effect of IL-6 on Alveolar Fibroblast Proliferation in Interstitial Lung DiseasesClinical Immunology and Immunopathology, 1996
- Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.The Journal of Experimental Medicine, 1996
- Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity.Journal of Clinical Investigation, 1994
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- IL-6 induces hepatic inflammation and collagen synthesisin vivoClinical and Experimental Immunology, 1994
- Endogenous interleukin 6 plays an obligatory role in interleukin 4‐dependent human IgE synthesisEuropean Journal of Immunology, 1989
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980